Author Archive: Tracy Cooley

Tracy was the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues.

Latest Posts

New PhRMA Report: A Decade of Innovation in Rare Diseases


Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in Rare Diseases,” which highlights 10 years of progress in understanding rare diseases and drug development resulting in groundbreaking therapies. According to the report, more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development. The Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Op-Ed: As I Lay Dying

Former staff writer for the LA Times Laurie Becklund shares her experience ‘climbing ladders and falling down chutes’ as a metastatic breast cancer patient in this powerful op-ed. Becklund died in February, but left behind insights on how to improve the care and treatment of life-threatening diseases based on her first-hand experience. Becklund advocates for the creation of a ‘new system of data collection and an open, online, broad-range database about patient histories.’ This information Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post

FOX Business: BIO CEO Jim Greenwood Discusses Future of Medicine


BIO President and CEO Jim Greenwood appeared on Fox Business during the 17th Annual BIO CEO & Investor Conference in New York City to discuss the future of medicine. Against a backdrop of policy discussions focused on how to encourage and incentivize innovation, this week’s conference hosted a record number of partnering meetings, as Greenwood emphasizes in the interview. Greenwood goes on to point out that investors closely follow policy trends, and their interest in Read More >

Events, Health  |  1 Comment  |  Email This Post
Tags: , , , , ,

BIO CEO & Investor Conference Kicks Off in NYC

CEO2013_115x75_Thumbnail copy

The 17th Annual BIO CEO & Investor Conference opened today with a record number of partnering meetings and company presentations, in addition to key policy, business, and science panels highlighting the biotech issues of the day. During the Welcome & Opening Plenary session, BIO President & CEO Jim Greenwood spoke with Energy & Commerce Committee Chairman Fred Upton (R-MI) and Congresswoman Diana DeGette (D-CO) about the 21st Century Cures Initiative, a comprehensive effort to accelerate the discovery, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

How Industry Rates Interactions with the FDA


Kicking off day one of the BIO CEO & Investor Conference in New York City, panelists in the ‘How Industry Rates Interactions with the FDA’ session brought attendees good news – communication with the FDA has improved overall. “The improvements we have seen in increased communications between FDA and sponsors is based on a continuous dialogue that has been established over the past several years in which BIO has been at the forefront,” said Jonathan Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,